Koki Maeda
Overview
Explore the profile of Koki Maeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Takei K, Konno H, Katsumata S, Maeda K, Kojima H, Isaka M, et al.
Gen Thorac Cardiovasc Surg
. 2024 Jul;
73(3):171-179.
PMID: 39008147
Objective: The stair-climbing test (SCT) is used as a surrogate for cardiopulmonary exercise testing, which measures maximal oxygen uptake, and considered a useful method for assessing exercise capacity in thoracic...
12.
Kamimura G, Aoki M, Iwamoto M, Tsuneyoshi Y, Morizono S, Umehara T, et al.
Gen Thorac Cardiovasc Surg
. 2024 Jul;
72(10):695.
PMID: 38980444
No abstract available.
13.
Hayasaki A, Kuriyama N, Kaluba B, Sakamoto T, Komatsubara H, Maeda K, et al.
Surg Case Rep
. 2024 Jul;
10(1):165.
PMID: 38954117
Background: Hepatopancreatoduodenectomy (HPD) is a high-risk surgical procedure. Delayed division of the pancreatic parenchyma (DDPP) was reported as a novel technique in HPD for reducing postoperative pancreatic fistula. However, it...
14.
Jotatsu Y, Sung S, Wu M, Takeda S, Hirata Y, Maeda K, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928352
Prostate cancer (PC) is the most common cancer diagnosed in men worldwide. Currently, castration-resistant prostate cancer (CRPC), which is resistant to androgen deprivation therapy, has a poor prognosis and is...
15.
Kamimura G, Aoki M, Iwamoto M, Tsuneyoshi Y, Morizono S, Umehara T, et al.
Gen Thorac Cardiovasc Surg
. 2024 May;
73(1):39-44.
PMID: 38805108
Introduction: Lung adenocarcinoma with a preoperatively elevated serum carcinoembryonic antigen (CEA) value has a relatively poor postoperative prognosis. Although surgical resection generally results in a reduction in the CEA value,...
16.
Hayashi K, Shigemura K, Tanimoto H, Kumagai K, Gonzales R, Yang Y, et al.
Sci Rep
. 2024 May;
14(1):12001.
PMID: 38796538
The current study aimed to establish an experimental model in vitro and in vivo of urinary crystal deposition on the surface of ureteral stents, to evaluate the ability to prevent...
17.
Nagayama Y, Yoshioka S, Ichikura-Iida A, Inoue T, Maeda K, Otani M, et al.
CEN Case Rep
. 2024 May;
13(6):534-544.
PMID: 38750297
Tertiary lymphoid tissue (TLT) develops at sites of chronic immune stimulation, including infection, autoimmune disease, transplant rejection, and cancer. Recently, TLT has been focused on an indicator for poor renal...
18.
Maeda K, Kuriyama N, Noguchi D, Ito T, Gyoten K, Hayasaki A, et al.
PLoS One
. 2024 May;
19(5):e0292628.
PMID: 38748746
Hepatic ischemia-reperfusion injury causes liver damage during surgery. In hepatic ischemia-reperfusion injury, the blood coagulation cascade is activated, causing microcirculatory incompetence and cellular injury. Coagulation factor Xa (FXa)- protease-activated receptor...
19.
Yang Y, Shigemura K, Maeda K, Moriwaki M, Chen K, Nakano Y, et al.
Int J Urol
. 2024 Jan;
31(5):459-463.
PMID: 38239011
Prostatitis is a major urological disease affecting 25%-50% of men over their lifetime. However, prostatitis is often overlooked in nonurologic departments due to its sometimes indeterminate symptoms. In this review,...
20.
Sawada H, Taniguchi Y, Iizuka S, Ikeda T, Aga M, Hamakawa Y, et al.
Case Rep Oncol
. 2023 Dec;
16(1):1558-1567.
PMID: 38089732
Introduction: C-ros oncogene 1 (ROS1) translocation is an oncogenic driver-mutation identified in 1-2% of non-small-cell lung cancer (NSCLC) cases. Although crizotinib, a tyrosine kinase inhibitor (TKI) against ALK/ROS1, is known...